1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride has been researched along with Abnormalities, Drug-Induced in 2 studies
*Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, TH; Chung, MK; Jang, BS; Kang, SS; Kim, CY; Kim, JC; Kim, SH; Shin, DH | 1 |
| Chung, MK; Han, SS; Kim, JC; Shin, HC; Yun, HI | 1 |
2 other study(ies) available for 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Fetal Weight; Fetus; Fluoroquinolones; Gestational Age; Maternal-Fetal Exchange; Molecular Structure; Organ Size; Piperazines; Placenta; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley | 2003 |
Embryo lethality and teratogenicity of a new fluoroquinolone antibacterial DW-116 in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Body Weight; Bone and Bones; Eating; Female; Fetal Death; Fluoroquinolones; Male; Maternal-Fetal Exchange; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Teratogens | 2000 |